The HLA typing for the transplants market is expected to reach USD 968 million by 2025 from USD 656 million in 2019, at a CAGR of 6.7%. North America is a well-established market for medical devices.
Request Sample of Report @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=96374742
The demand for transplant diagnostic products for HLA typing is expected to grow mainly due to factors such as technological advancements, the growing number of diagnostic centers & hospitals, increased applications in patient profiling, and rising public-private investments to support product development.
Key Market Players
Some of the players in the HLA typing for transplants market are Thermo Fisher Scientific, Inc. (US), QIAGEN N.V. (Netherlands), Illumina (US), CareDx, Inc. (US), Immucor, Inc. (US), Bio-Rad Laboratories, Inc. (US), F. Hoffman-La Roche Ltd. (Switzerland), Hologic, Inc. (US), Luminex (US), Biofortuna (UK), Takara Bio (Japan), Omixon (Hungary).
HLA typing for the transplants market showed that product launches, expansions, agreements, partnerships, collaborations, and acquisitions were the most widely adopted growth strategies in the market.
Thermo Fisher Scientific is the leading player in the global HLA typing for the transplants market. The company has a broad range of automated instruments for antibody screening and analysis, semi-automated systems for serological assays, standalone systems & reagents for molecular and non-molecular assay procedures, including HLA typing products for transplant.
Download PDF Brochure @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=96374742
QIAGEN ((Netherlands) holds a leading position in the HLA typing for the transplant industry due to its vast product portfolio in molecular diagnostics and analytics. Over the years, the company has focused on multiple growth strategies, such as agreements, collaborations, and product launches. Along with this, the company has maintained continuous leadership in the HLA typing for the transplants industry with its huge consumer base.
A detailed market estimation approach was followed to estimate and validate the value of the HLA typing for the transplants market and other dependent submarkets, as mentioned below.
· Key players in the global HLA typing for transplants market were identified through secondary research, and their global market shares were determined through primary and secondary research.
· The research methodology included the study of the annual and quarterly financial reports & regulatory filings of significant market players as well as interviews with industry experts for detailed market insights.
· All percentage shares, splits, and breakdowns for the global HLA typing for the transplants market were determined using secondary sources and verified through primary sources.
· All key macro indicators affecting the revenue growth of market segments and subsegments have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the validated and verified quantitative & qualitative data.
· The gathered market data was consolidated and added to detailed inputs, analyzed, and presented in this report.
Request Custom Research @
https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=96374742
